Search Results - "Bozio, Catherine H."
-
1
Characteristics of and meningococcal disease prevention strategies for commercially insured persons receiving eculizumab in the United States
Published in PloS one (12-11-2020)“…Eculizumab is a licensed treatment for several rare, complement-mediated diseases. Eculizumab use is associated with an approximately 2,000-fold increased…”
Get full text
Journal Article -
2
Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine
Published in PloS one (07-09-2018)“…Increases in pneumococcal meningitis were reported from Ghanaian regions that lie in the meningitis belt in 2016-2017, despite introduction of 13-valent…”
Get full text
Journal Article -
3
US Infant Pertussis Incidence Trends Before and After Implementation of the Maternal Tetanus, Diphtheria, and Pertussis Vaccine
Published in JAMA pediatrics (01-04-2023)“…Infants younger than 1 year have the highest burden of pertussis morbidity and mortality. In 2011, the US introduced tetanus toxoid, reduced diphtheria toxoid,…”
Get more information
Journal Article -
4
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
Published in The New England journal of medicine (07-10-2021)“…A study with a test-negative design analyzed 41,552 admissions to 187 hospitals and 21,522 visits to 221 EDs or urgent care clinics. The mRNA-based vaccines…”
Get full text
Journal Article -
5
Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases—United States, 2011–2015
Published in Clinical infectious diseases (06-12-2021)“…Abstract Background Incidence of invasive disease due to Haemophilus influenzae serotype a (Hia) increased an average of 13% annually from 2002 through 2015…”
Get full text
Journal Article -
6
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
Published in MMWR. Morbidity and mortality weekly report (18-02-2022)“…CDC recommends that all persons aged ≥12 years receive a booster dose of COVID-19 mRNA vaccine ≥5 months after completion of a primary mRNA vaccination series…”
Get full text
Journal Article Newsletter -
7
Coronavirus Disease 2019 (COVID-19) in Americans Aboard the Diamond Princess Cruise Ship
Published in Clinical infectious diseases (18-05-2021)“…The Diamond Princess cruise ship was the site of a large outbreak of coronavirus disease 2019 (COVID-19). Of 437 Americans and their travel companions on the…”
Get full text
Journal Article -
8
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
Published in MMWR. Morbidity and mortality weekly report (28-01-2022)“…Estimates of COVID-19 mRNA vaccine effectiveness (VE) have declined in recent months (1,2) because of waning vaccine induced immunity over time,* possible…”
Get full text
Journal Article Newsletter -
9
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
Published in MMWR. Recommendations and reports (25-09-2020)“…This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) for use of meningococcal vaccines in the…”
Get full text
Journal Article -
10
Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza-Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012–2019
Published in Clinical infectious diseases (13-09-2024)“…Abstract Background Pneumonia is common in adults hospitalized with laboratory-confirmed influenza, but the association between timeliness of influenza…”
Get full text
Journal Article -
11
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance
Published in The Journal of infectious diseases (15-06-2023)“…Data assessing protection conferred from COVID-19 mRNA vaccination and/or prior SARS-CoV-2 infection during Delta and Omicron predominance periods in the…”
Get full text
Journal Article -
12
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022
Published in MMWR. Morbidity and mortality weekly report (04-03-2022)“…The efficacy of the BNT162b2 (Pfizer-BioNTech) vaccine against laboratory-confirmed COVID-19 exceeded 90% in clinical trials that included children and…”
Get full text
Journal Article Newsletter -
13
Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016
Published in The Journal of infectious diseases (31-10-2019)“…During 2014, 4 regions in Togo within the African meningitis belt implemented vaccination campaigns with meningococcal serogroup A conjugate vaccine (MACV)…”
Get full text
Journal Article -
14
-
15
Relative Risks of COVID-19–Associated Hospitalizations and Clinical Outcomes by Age and Race/Ethnicity—March 2020–March 2021
Published in Open forum infectious diseases (01-10-2022)“…Abstract Background Limited data exist on population-based risks and risk ratios (RRs) of coronavirus disease 2019 (COVID-19)–associated hospitalizations and…”
Get full text
Journal Article -
16
Cardiac Troponin T, a Sarcomeric AKAP, Tethers Protein Kinase A at the Myofilaments
Published in The Journal of biological chemistry (07-01-2011)“…Efficient and specific phosphorylation of PKA substrates, elicited in response to β-adrenergic stimulation, require spatially confined pools of PKA anchored in…”
Get full text
Journal Article -
17
Patient and Epidemiological Factors Associated With Influenza Testing in Hospitalized Adults With Acute Respiratory Illnesses, 2016–2017 to 2019–2020
Published in Open forum infectious diseases (01-04-2023)“…Abstract Background Data are limited on influenza testing among adults with acute respiratory illness (ARI)–associated hospitalizations. We identified factors…”
Get full text
Journal Article -
18
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021
Published in MMWR. Morbidity and mortality weekly report (05-11-2021)“…Previous infection with SARS-CoV-2 (the virus that causes COVID-19) or COVID-19 vaccination can provide immunity and protection from subsequent SARS-CoV-2…”
Get full text
Journal Article Newsletter -
19
Clinical Outcomes of US Adults Hospitalized for COVID-19 and Influenza in the Respiratory Virus Hospitalization Surveillance Network, October 2021-September 2022
Published in Open forum infectious diseases (01-01-2024)“…Severe outcomes were common among adults hospitalized for COVID-19 or influenza, while the percentage of COVID-19 hospitalizations involving critical care…”
Get full text
Journal Article -
20
Association of Chronic Medical Conditions With Severe Outcomes Among Nonpregnant Adults 18-49 Years Old Hospitalized With Influenza, FluSurv-NET, 2011-2019
Published in Open forum infectious diseases (01-12-2023)“…Older age and chronic conditions are associated with severe influenza outcomes; however, data are only comprehensively available for adults ≥65 years old…”
Get full text
Journal Article